Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGF Ointment for EGFR Inhibitor-Related Skin Side Effects
NCT02284139Phase 3Completed
- Start
- Apr 2015
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nepidermin in toxicoderma (cADR). Started Apr 2015; status: completed.
02
Drugs
nepidermin
03
Conditions
toxicoderma (cADR)
Beyond the preview
Go deeper on NCT02284139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284139.